Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial is a research paper published in Annals of Oncology (2025). On theSindex it has a DataRank of 0.345. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: UG1CA189829
National Institutes of Health
Grant: UG1CA233339
National Institutes of Health
Grant: U10CA180794
National Institutes of Health
Grant: UG1CA233193
National Institutes of Health
Grant: UG1CA233196
National Institutes of Health
Grant: UG1CA233277
National Institutes of Health
Grant: UG1CA233180
National Institutes of Health
Grant: U10CA180821
National Institutes of Health
Grant: UG1CA233234
National Institutes of Health
Grant: UG1CA233320
National Institutes of Health
Grant: UG1CA233270
National Institutes of Health
Grant: U10CA180888
National Institutes of Health
Grant: U10CA180820
National Cancer Institute
Sanofi
FWCI
8.31
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals